Sir Chris Hoy reveals prostate cancer diagnosis gave him ‘new purpose’ as he launches mass screening drive - The Olympian ...

Starting next year, Louisiana could require health insurance plans to cover prostate cancer screenings starting at age 40, ...

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

Leading figures from the world of business and sport, including Sir Chris Hoy and Sir Tom Hunter, have urged tens of ...

Alicia Morgans, MD, MPH, offers advice to patients newly diagnosed with prostate cancer and reviews educational resources available for patients and their caregivers. Alicia Morgans, M.D., MPH: When ...

Early detection plays a major role in recovering from cancer. Dr Chawla shares five symptoms that can help people over 50 ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

Prostate cancer is the most common cancer in men in the United Kingdom, with roughly 55,300 new cases diagnosed every year ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

By Tim BakerClose readers of this blog and, indeed, the PCFA website, may have picked up on the carefully guarded secret that ...